Trial Parameters
Condition Sepsis
Sponsor Beth Israel Deaconess Medical Center
Study Type OBSERVATIONAL
Phase N/A
Enrollment 4,200
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2006-04
Completion 2028-12
All Conditions
Brief Summary
The purpose of this investigation is to evaluate how early biomarkers of infection and inflammation perform in identifying patients at risk for poor outcome in sepsis and septic shock.
Eligibility Criteria
Inclusion Criteria for Infected subjects: * Age 18 years of age or older * Confirmed or suspected infection Inclusion Criteria for Control Subjects: * Age 18 years of age or older * A non-infectious clinical presentation to include * Normal white blood cell count ( \> 4,000 and/or \< 12,000) * Normothermia ( \> 96.5 and/or less 100.4) * Absence of the following clinical complaints: productive cough, fever, pyuria, rash * No evidence of acute coronary syndrome Exclusion Criteria for Control Subjects: \- Suspected infection